MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
OPKO Health Total Current Liabilities 2011-2026 | OPK
Annual Total Current Liabilities OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 193 M | 200 M | 213 M | 330 M | 375 M | 249 M | 288 M | 312 M | 263 M | 252 M | 83.1 M | 91.8 M | 52.4 M | 18.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 375 M | 18.8 M | 209 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
68.7 M | $ 22.01 | -11.09 % | $ 638 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 17.01 | - | $ 179 M |  China |
 |
Agilent Technologies
A
|
1.71 B | $ 118.28 | 0.43 % | $ 36 B | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 21.69 | 3.53 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 1.65 | 0.61 % | $ 2.19 M | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 428.82 | 0.48 % | $ 12.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 187.3 | 3.06 % | $ 9.28 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.17 | 1.34 % | $ 386 M | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 8.99 | 1.07 % | $ 1.15 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 18.09 | 1.26 % | $ 405 M | USA |
 |
Natera
NTRA
|
310 M | $ 216.86 | 0.82 % | $ 21.3 B | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 14.8 | -0.8 % | $ 447 M | USA |
 |
Guardant Health
GH
|
303 M | $ 90.9 | -1.46 % | $ 11.4 B | USA |
 |
Personalis
PSNL
|
31.1 M | $ 6.12 | 0.82 % | $ 363 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 124.97 | 0.68 % | $ 10.3 B |  Irlanda |
 |
Illumina
ILMN
|
1.55 B | $ 138.93 | -2.56 % | $ 22.1 B | USA |
 |
Soleno Therapeutics
SLNO
|
61.4 M | $ 52.94 | -0.01 % | $ 2.69 B | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 5.3 | -1.12 % | $ 221 M | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 2.04 | -3.33 % | $ 9.02 M | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Biomerica
BMRA
|
1.74 M | $ 2.19 | -0.9 % | $ 5.03 M | USA |
 |
Thermo Fisher Scientific
TMO
|
15.2 B | $ 472.26 | -0.23 % | $ 178 B | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 90.2 | 4.7 % | $ 6.09 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 256.45 | -0.19 % | $ 21.3 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 132.46 | -5.01 % | $ 6.19 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 59.1 | -0.72 % | $ 3.53 B | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 9.14 | -0.44 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 188.42 | -0.38 % | $ 20.9 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |